Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring

Abstract

Vancomycin is frequently used in haemodialysis (HD) patients but generally accepted target serum ranges and dosing strategy are still lacking in this group. Based on retrospective analysis of data from 118 HD patients treated with vancomycin the interdialytic elimination constant (K_e), apparent volume of distribution (Vd) and dialysis efficacy were calculated. The influence of possible clinical variables on the pharmacokinetic parameters of vancomycin have been tested. The median of K_e in interdialytic periods, corresponding half-life and Vd were 0.0073 h⁻¹, 95.0 h and 0.87 L/kg, respectively. We found significant positive correlation between time in dialysis program and K_e. The Vd correlated best with lean body mass (LBM). For high- and low flux membrane HD of 4 hours duration the decline in vancomycin levels was 20.88% and 12.86%, respectively. Based on these data loading dose for vancomycin in HD patient should be calculated as 24.483 × LBM (kg) + 455 mg. The utility of this equation for entire HD population should be also verified prospectively.

Keywords:

• Vancomycin
• haemodialysis
• pharmacokinetics
• dosing
• therapeutic drug monitoring

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was supported by Charles University projects Progres Q25 and SVV 260 523.